New Brunswick Health Research Foundation
11
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.1%
1 terminated/withdrawn out of 11 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comprehensive Assessment of Neurodegeneration and Dementia
Role: collaborator
READYorNot[TM] Brain-Based Disabilities Trial
Role: collaborator
Evaluation of the Impact of a Dietary and Nutritional Intervention on Persistent Post-concussive Symptoms
Role: collaborator
Calibration of a Wrist Cuff Blood Pressure Device, According to the AAMI/ESH/ISO Universal Standard
Role: collaborator
Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)
Role: collaborator
Improving Individual Glycemic Response With Exercise Intensity
Role: collaborator
Clinical Calibration & Validation of a Next-Generation Blood Pressure Monitor for Patient Management
Role: collaborator
Zoomers for the Capital Region: A Peer-Led Exercise Program for Aging Adults
Role: collaborator
The Irisin and Metabolic Exercise Training Study
Role: collaborator
Comorbid Mental Disease and Heart Disease in Men
Role: collaborator
Testing an Intervention to Foster Hope for Cancer Survivors With Lymphedema
Role: collaborator
All 11 trials loaded